Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors.
Deken MA, Niewola-Staszkowska K, Peyruchaud O, Mikulčić N, Antolić M, Shah P, Cheasty A, Tagliavini A, Nizzardo A, Pergher M, Ziviani L, Milleri S, Pickering C, Lahn M, van der Veen L, Di Conza G, Johnson Z.
Deken MA, et al. Among authors: peyruchaud o.
Immunooncol Technol. 2023 Apr 8;18:100384. doi: 10.1016/j.iotech.2023.100384. eCollection 2023 Jun.
Immunooncol Technol. 2023.
PMID: 37234285
Free PMC article.